Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haifeng Song

Showing results (131-140 of 151) with videos related to

Pageof 16
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 6, 2023
Phase I, Randomized, Placebo-Controlled, Dose-Escalation Study of GB223, a Fully-Humanized Monoclonal Antibody to RANKL, in Healthy Chinese AdultsChen Li, Haiyan Liu, Yixiang Liao, et al.
International Immunopharmacology|August 16, 2019
A randomized controlled dose-escalation study of SSS07, a humanized rabbit anti-human TNF alpha antibody, in healthy Chinese adultsQi Wang, Xinyao Xie, Feng Su, et al.
World Journal of Urology|July 13, 2022
Ultrasound-guided renal access and balloon dilation for PCNL in the prone position: results of a multicenter prospective observational studyBoxing Su, Haifeng Song, Zesong Yang, et al.
International Immunopharmacology|August 15, 2020
Corrigendum to 'A randomized controlled, dose-escalation study of SSS07, a humanized rabbit anti-human TNF alpha antibody, in healthy Chinese adults'. [Int. Immunopharmacol. 75 (2019) 105807]Qi Wang, Xinyao Xie, Feng Su, et al.
Expert Opinion on Investigational Drugs|June 30, 2020
A randomized phase I clinical trial comparing the pharmacokinetic, safety, and immunogenicity of potential biosimilar recombinant human HER2 monoclonal antibody for injection and trastuzumab in healthy Chinese adultsJiaxue Wang, Suping Niu, Wenliang Dong, et al.
Expert Opinion on Biological Therapy|July 8, 2021
Pharmacokinetic bioequivalence, safety, and immunogenicity of GB222, a bevacizumab biosimilar candidate, and bevacizumab in Chinese healthy males: a randomized clinical trialWenliang Dong, Min Chen, Suping Niu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 10, 2026
Safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of a novel anti-TSLP bispecific antibody (GR2002) in healthy Chinese adults: a randomized, placebo-controlled phase 1 trialRui Ding, Fan Huang, Ziyan Ding, et al.
Vaccine|February 28, 2016
Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in miceKarin Lövgren Bengtsson, Haifeng Song, Linda Stertman, et al.
Molecular Genetics & Genomic Medicine|June 6, 2019
A comprehensive assessment of Next-Generation Sequencing variants validation using a secondary technologyJianchao Zheng, Hongyun Zhang, Santasree Banerjee, et al.
Cardiovascular Research|June 4, 2024
Cardiomyocyte βII spectrin plays a critical role in maintaining cardiac function by regulating mitochondrial respiratory functionRongjin Yang, Banjun Ruan, Rutao Wang, et al.
Pageof 16

Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 6, 2023
Phase I, Randomized, Placebo-Controlled, Dose-Escalation Study of GB223, a Fully-Humanized Monoclonal Antibody to RANKL, in Healthy Chinese AdultsChen Li, Haiyan Liu, Yixiang Liao, et al.
International Immunopharmacology|August 16, 2019
A randomized controlled dose-escalation study of SSS07, a humanized rabbit anti-human TNF alpha antibody, in healthy Chinese adultsQi Wang, Xinyao Xie, Feng Su, et al.
World Journal of Urology|July 13, 2022
Ultrasound-guided renal access and balloon dilation for PCNL in the prone position: results of a multicenter prospective observational studyBoxing Su, Haifeng Song, Zesong Yang, et al.
International Immunopharmacology|August 15, 2020
Corrigendum to 'A randomized controlled, dose-escalation study of SSS07, a humanized rabbit anti-human TNF alpha antibody, in healthy Chinese adults'. [Int. Immunopharmacol. 75 (2019) 105807]Qi Wang, Xinyao Xie, Feng Su, et al.
Expert Opinion on Investigational Drugs|June 30, 2020
A randomized phase I clinical trial comparing the pharmacokinetic, safety, and immunogenicity of potential biosimilar recombinant human HER2 monoclonal antibody for injection and trastuzumab in healthy Chinese adultsJiaxue Wang, Suping Niu, Wenliang Dong, et al.
Expert Opinion on Biological Therapy|July 8, 2021
Pharmacokinetic bioequivalence, safety, and immunogenicity of GB222, a bevacizumab biosimilar candidate, and bevacizumab in Chinese healthy males: a randomized clinical trialWenliang Dong, Min Chen, Suping Niu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 10, 2026
Safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of a novel anti-TSLP bispecific antibody (GR2002) in healthy Chinese adults: a randomized, placebo-controlled phase 1 trialRui Ding, Fan Huang, Ziyan Ding, et al.
Vaccine|February 28, 2016
Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in miceKarin Lövgren Bengtsson, Haifeng Song, Linda Stertman, et al.
Molecular Genetics & Genomic Medicine|June 6, 2019
A comprehensive assessment of Next-Generation Sequencing variants validation using a secondary technologyJianchao Zheng, Hongyun Zhang, Santasree Banerjee, et al.
Cardiovascular Research|June 4, 2024
Cardiomyocyte βII spectrin plays a critical role in maintaining cardiac function by regulating mitochondrial respiratory functionRongjin Yang, Banjun Ruan, Rutao Wang, et al.
Pageof 16